FDA warns of risk of peripheral neuropathy with fluoroquinolones

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2013年 / 1466卷 / 1期

关键词：

D O I：

10.1007/s40278-013-5267-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：2 / 2

相关论文

共 50 条

[1] Fluoroquinolones and Peripheral Neuropathy
不详
[J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2013, 55 (1429): : 89 - 90
[2] FDA issues neuropathy warning on fluoroquinolones
不详
[J]. FORMULARY, 2013, 48 (09) : 305 - 305
[3] PERIPHERAL NEUROPATHY ASSOCIATED WITH FLUOROQUINOLONES
AOUN, M
JACQUY, C
DEBUSSCHER, L
BRON, D
LEHERT, M
NOEL, P
VANDERAUWERA, P
[J]. LANCET, 1992, 340 (8811): : 127 - 127
[4] Peripheral neuropathy associated with fluoroquinolones
Cohen, JS
[J]. ANNALS OF PHARMACOTHERAPY, 2001, 35 (12) : 1540 - 1547
[5] Peripheral neuropathy with oral fluoroquinolones
[J]. Reactions Weekly, 2019, 1752 (1) : 11 - 11
[6] ADRAC warns of peripheral neuropathy with nitrofurantoin
[J]. Reactions Weekly, 2001, 876 (1) : 3 - 3
[7] CONTINUED REPORTS OF PERIPHERAL NEUROPATHY WITH FLUOROQUINOLONES
Aschenbrenner, Diane S.
[J]. AMERICAN JOURNAL OF NURSING, 2013, 113 (12) : 23 - 23
[8] Comment: peripheral neuropathy syndrome and fluoroquinolones
Tillotson, GS
[J]. ANNALS OF PHARMACOTHERAPY, 2001, 35 (12) : 1673 - 1674
[9] FDA warns of seizure risk with dalfampridine
[J]. Reactions Weekly, 2012, 1412 (1) : 2 - 2
[10] Comment: peripheral neuropathy syndrome and fluoroquinolones - Reply
Cohen, JS
[J]. ANNALS OF PHARMACOTHERAPY, 2001, 35 (12) : 1674 - 1674

← 1 2 3 4 5 →